Medical News

RSS

G8 will fall short on their promises to cut child and maternal deaths, says World Vision

Last year, the G8 pledged $20 billion through 2012 to fund hunger alleviation programs, yet no mechanism exists to track the disbursement of the funds.

30 Jun 2010

Insuring your health: Part-time workers to get help on health insurance – but not now

In this Kaiser Health News consumer column, Michelle Andrews writes: "Sarah Rose Nordgren works 25 to 30 hours a week as a waitress at an upscale restaurant in Chapel Hill, N.C."

30 Jun 2010

Vivakor completes phase I SBIR research grant, submits final report to National Eye Institute

Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.

30 Jun 2010

Mayo Clinic biostatistician become director of CALGB

In a move that will improve efficiency and collaboration in cancer research, Mayo biostatistician Daniel Sargent, Ph.D., will become director of the Statistical Center for the Cancer and Leukemia Group B (CALGB), a national association of cancer researchers funded primarily by the National Cancer Institute (NCI).

30 Jun 2010

Health law provisions kicking in; States prepare for high-risk insurance pool implementation

Three months after health reform was enacted, state leaders are beginning to make decisions about implementing the new law, Politico reports: "With the messy politics of health reform, the burden of balancing state budgets and the goal of expanding health coverage, lawmakers at the state level have had mixed reactions."

30 Jun 2010

Physically-active women have lower risk of dementia in later life

Women who are physically active at any point over the life course (teenage, age 30, age 50, late life) have lower risk of cognitive impairment in late-life compared to those who are inactive, but teenage physical activity appears to be most important.

30 Jun 2010

SMART-UR launches Client Service Center to assist with medical Utilization Review request process

Gregg Bernhard, COO of SMART-UR, announced the company has launched a Client Services Center to assist its clients with the processing of medical Utilization Review (UR) requests.

30 Jun 2010

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

30 Jun 2010

UK scientists find no link between mobile phone masts and early childhood cancers

UK scientists have found no evidence to suggest that children whose mothers lived close to mobile phone base stations during pregnancy face an increased risk of early childhood cancers.

30 Jun 2010

Aeolus AEOL 10150 study confirms ability to rescue skin from deleterious effects of CEES

Aeolus Pharmaceuticals, Inc. reported that researchers from National Jewish Health and the University of Colorado Anschutz Medical Campus have completed studies demonstrating that AEOL 10150 provides statistically significant protection of the skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in mice and in a human cell culture model.

30 Jun 2010

Metabolex, Sanofi-Aventis sign global license deal to develop GPR119 for type 2 diabetes treatment

Metabolex and Sanofi-Aventis announced today that they have entered into a global license and development agreement for the research, development, manufacture and commercialization of small molecules that modulate the G-protein coupled receptor 119 (GPR119), a receptor in the gut and pancreas that interacts with bioactive lipids to stimulate glucose-dependent incretin and insulin secretion.

30 Jun 2010

Experts evlauate impact of Medicare Part D program on independent and chain pharmacies

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Medicare Part D) added prescription drug coverage to Medicare beginning in January 2006.

30 Jun 2010

2 new studies add to evidence of risks with diabetes drug Avandia as FDA prepares to debate it's safety

The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.

30 Jun 2010

Lack of reimbursements limit drug-eluting stent market across Latin America

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.

30 Jun 2010

Counseling programs increase mammography compliance among low-income women

Even with health insurance, low-income women had lower rates of mammography screening than middle-class women, but a counseling program increased the likelihood of screening.

30 Jun 2010

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.

30 Jun 2010

Daily Nation reports on USAID's 2-year, $11.5M market linkages initiative to improve food security in East Africa

USAID will contribute $11.5 million for the Market Linkages Initiative (MLI), a two-year program aimed at promoting trade in "staple foods" in East Africa, the Daily Nation reports.

30 Jun 2010

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.

30 Jun 2010

When it comes to decision making, older adults fare as well as juniors

Many people believe that getting older means losing a mental edge, leading to poor decision-making. But a new study from North Carolina State University shows that when it comes to making intuitive decisions - using your "gut instincts" - older adults fare as well as their juniors.

30 Jun 2010

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.

30 Jun 2010

Medical News

G8 will fall short on their promises to cut child and maternal deaths, says World Vision

Insuring your health: Part-time workers to get help on health insurance – but not now

Vivakor completes phase I SBIR research grant, submits final report to National Eye Institute

Mayo Clinic biostatistician become director of CALGB

Health law provisions kicking in; States prepare for high-risk insurance pool implementation

Physically-active women have lower risk of dementia in later life

SMART-UR launches Client Service Center to assist with medical Utilization Review request process

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

UK scientists find no link between mobile phone masts and early childhood cancers

Aeolus AEOL 10150 study confirms ability to rescue skin from deleterious effects of CEES

Metabolex, Sanofi-Aventis sign global license deal to develop GPR119 for type 2 diabetes treatment

Experts evlauate impact of Medicare Part D program on independent and chain pharmacies

2 new studies add to evidence of risks with diabetes drug Avandia as FDA prepares to debate it's safety

Lack of reimbursements limit drug-eluting stent market across Latin America

Counseling programs increase mammography compliance among low-income women

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Daily Nation reports on USAID's 2-year, $11.5M market linkages initiative to improve food security in East Africa

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

When it comes to decision making, older adults fare as well as juniors

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News